Study offers updated guidelines on useof breast MR imaging
Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.
Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.
Among the recommendations is that MRI is not a substitute for screening or diagnostic mammography and, when indicated, diagnostic breast ultrasound, the guidelines state. But when cancer is found in the lymph nodes but not the breast, MRI can find the location of cancer in the breast in nearly 60% of women.
The guidelines were developed by Dr. Constance Lehman, a professor of radiology at the University of Washington and director of breast imaging at Seattle Cancer Care Alliance, and colleagues. They were based on an extensive review of published, peerreviewed studies.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
